Literature DB >> 10980395

Probability of finding HLA-mismatched related or unrelated marrow or cord blood donors.

P G Beatty1, K M Boucher, M Mori, E L Milford.   

Abstract

Given recent improvements in the technology of transplantation and histocompatibility testing, it is now possible to contemplate using related or unrelated allogeneic hematologic stem cell donors with high degrees of HLA disparity. This paper is a follow-up of an earlier publication on the probability of finding a matched donor (Transplantation 60:778-783, 1995) and addresses the probability of finding a partially mismatched donor. Assuming that a four of six antigen HLA-A, -B, -DR match is acceptable, it is possible to find unrelated donors for patients of any race from a putative registry with fewer than 10,000 potential donors. Further, storing cord blood from newborns in families with a known genetic disease would yield an acceptable future stem cell transplant product in nearly 40% of cases. These results show the potential impact of cord blood donors and emphasize the importance of improvements in transplantation using partially mismatched donors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10980395     DOI: 10.1016/s0198-8859(00)00138-5

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  16 in total

Review 1.  Genesis of hematopoietic stem cells in vitro and in vivo: new insights into developmental maturation.

Authors:  Michael Kyba
Journal:  Int J Hematol       Date:  2005-05       Impact factor: 2.490

Review 2.  Umbilical cord blood banking: an update.

Authors:  Merlin G Butler; Jay E Menitove
Journal:  J Assist Reprod Genet       Date:  2011-05-27       Impact factor: 3.412

3.  Effect of conditioning regimen intensity on acute myeloid leukemia outcomes after umbilical cord blood transplantation.

Authors:  Betul Oran; John E Wagner; Todd E DeFor; Daniel J Weisdorf; Claudio G Brunstein
Journal:  Biol Blood Marrow Transplant       Date:  2011-01-11       Impact factor: 5.742

4.  Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities.

Authors:  Juliet N Barker; Courtney E Byam; Nancy A Kernan; Sinda S Lee; Rebecca M Hawke; Kathleen A Doshi; Deborah S Wells; Glenn Heller; Esperanza B Papadopoulos; Andromachi Scaradavou; James W Young; Marcel R M van den Brink
Journal:  Biol Blood Marrow Transplant       Date:  2010-08-25       Impact factor: 5.742

5.  Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor.

Authors:  Navneet S Majhail; Claudio G Brunstein; Marcie Tomblyn; Avis J Thomas; Jeffrey S Miller; Mukta Arora; Dan S Kaufman; Linda J Burns; Arne Slungaard; Philip B McGlave; John E Wagner; Daniel J Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2008-03       Impact factor: 5.742

6.  HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry.

Authors:  Loren Gragert; Mary Eapen; Eric Williams; John Freeman; Stephen Spellman; Robert Baitty; Robert Hartzman; J Douglas Rizzo; Mary Horowitz; Dennis Confer; Martin Maiers
Journal:  N Engl J Med       Date:  2014-07-24       Impact factor: 91.245

7.  Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy.

Authors:  Mary Eapen; John P Klein; Annalisa Ruggeri; Stephen Spellman; Stephanie J Lee; Claudio Anasetti; William Arcese; Juliet N Barker; Lee Ann Baxter-Lowe; Maria Brown; Marcelo A Fernandez-Vina; John Freeman; Wensheng He; Anna Paola Iori; Mary M Horowitz; Franco Locatelli; Susana Marino; Martin Maiers; Gerard Michel; Guillermo F Sanz; Eliane Gluckman; Vanderson Rocha
Journal:  Blood       Date:  2013-10-18       Impact factor: 22.113

8.  What is the most appropriate source for hematopoietic stem cell transplantation? Peripheral stem cell/bone marrow/cord blood.

Authors:  Itır Sirinoglu Demiriz; Emre Tekgunduz; Fevzi Altuntas
Journal:  Bone Marrow Res       Date:  2012-09-27

9.  The role of religious leaders and faith organisations in haemoglobinopathies: a review.

Authors:  Thelma K Toni-Uebari; Baba P D Inusa
Journal:  BMC Blood Disord       Date:  2009-08-15

10.  Likelihood of Proceeding to Allogeneic Hematopoietic Cell Transplantation in the United States after Search Activation in the National Registry: Impact of Patient Age, Disease, and Search Prognosis.

Authors:  Jason Dehn; Pintip Chitphakdithai; Bronwen E Shaw; Abby A McDonald; Steven M Devine; Linda J Burns; Stephen Spellman
Journal:  Transplant Cell Ther       Date:  2020-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.